Objective of the project:
The overall aim of the project is to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques. This also includes discovery of new taxa and bioactive molecules applicable in biotechnology and medicine. In the course of the project, partners from Austria, Czechia, Netherlands and South Africa will share knowledge, train students and disseminate results.
| Acronym | MYCOBIOMICS |
| Number and ID code of the project | N° 101008129, H2020-MSCA-RISE-2020 |
| Type of the project | MSCA-RISE |
| Coordinator | Helmholtz-Zentrum für Infektionsforschung GmbH |
| IMIC Principal Researcher | Mgr. Miroslav Kolařík, PhD. |
| Start of the project | 4/2021 |
| End of the project | 9/2025 |
| Total number of particip. countries | 4 |
| Of which from EU | 4 |
| Number of partners | 4 |
| Total funding for the project | 1 375 400 EUR |
| Funding for IMIC | 289 800 EUR |
| Provider | Program EU Horizon 2020 MSCA-RISE-2020 – Research and Innovation Staff Exchangee |